Latham & Watkins advised Avidity Biosciences on the deal, and Wilson Sonsini Goodrich & Rosati acted as patent counsel to Avidity. Avidity Biosciences, Inc. (Nasdaq: RNA),...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised the placement agents, RBC Capital Markets, LLC, and Berenberg Capital Markets LLC. Jumia Technologies AG (NYSE: JMIA) (Jumia), a leading e-commerce...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins advised Quantum Capital Partners and two of its portfolio companies, KODA Resources and QB Energy, on the transaction, Latham & Watkins and Davis...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised BCI – British Columbia Investment on the deal. British Columbia Investment Management Corporation (BCI) as part of a global leading infrastructure investors...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Advanced Micro Devices – AMD on the acquisition Of ZT Systems advised by Paul Weiss. AMD (NASDAQ: AMD) signed a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Seres Therapeutics, while Mayer Brown represented Société des Produits Nestlé on the deal. Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Archrock Inc. on the deal. Archrock, Inc. (NYSE: AROC) (Archrock) has announced the pricing of an upsized private offering by Archrock Partners,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Evos Finance B.V. on the refinancing. Evos Finance B.V. successfully completed a €950 million debt raise, refinancing a major part of its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Origis Energy on the deal. Origis Energy, a renewable energy and decarbonization solution platform, closed a US$71 million in tax equity financing...
You must be a Standard 1 Year member to access this content.
Latham & Watkins acted for Life Time Group Holdings Inc. Life Time Group Holdings, Inc. (NYSE: LTH) announced the pricing of the previously announced underwritten public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised scPharmaceuticals on the deal. scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Shift4Payments on the deal. Shift4 Payments, Inc. (NYSE: FOUR), a leader in integrated payments and commerce technology, has announced that its subsidiaries,...
You must be a Standard 1 Year member to access this content.
